Acute administration of ivacaftor to people with cystic fibrosis and a G551D-CFTR mutation reveals smooth muscle abnormalities.
JCI Insight
; 1(4): e86183, 2016 Apr 07.
Article
in En
| MEDLINE
| ID: mdl-27158673